NCT02427204View on ClinicalTrials.gov

Outcomes in Liver Disease Patient With and Without HIV Co-infection-Sub Study 2: HCV Treatment: Health Related Quality

CompletedOBSERVATIONAL

Enrollment

150

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

January 18, 2018

Study Completion Date

January 18, 2018

Conditions

Hepatitis C Infection

Trial Locations (1)

10029

Icahn School of Medicine, New York

Sponsors

Collaborators (1)

Gilead Sciences

All Listed Sponsors

collaborator

Gilead Sciences

INDUSTRY

lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT02427204 - Outcomes in Liver Disease Patient With and Without HIV Co-infection-Sub Study 2: HCV Treatment: Health Related Quality | Biotech Hunter | Biotech Hunter